vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Stock Yards Bancorp, Inc.（SYBT）财务数据对比。点击上方公司名可切换其他公司
Stock Yards Bancorp, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$104.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.7%），Stock Yards Bancorp, Inc.自由现金流更多（$154.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.9%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Stock Yards Bancorp是美国的区域银行控股企业，前身为1903年成立的派克维尔国民银行，总部仍位于肯塔基州阿巴拉契亚核心地带的派克维尔。旗下运营商业银行业务主体Community Trust Bank，以及位于列克星敦的信托机构Community Trust and Investment Company。
PBYI vs SYBT — 直观对比
营收规模更大
SYBT
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出16.1%
11.7%
自由现金流更多
SYBT
多$139.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $104.4M |
| 净利润 | — | $36.6M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 45.9% |
| 净利率 | — | 35.1% |
| 营收同比 | 27.7% | 11.7% |
| 净利润同比 | — | 15.5% |
| 每股收益（稀释后） | $0.26 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISYBT
| Q4 25 | $75.5M | $104.4M | ||
| Q3 25 | $54.5M | $101.5M | ||
| Q2 25 | $52.4M | $97.8M | ||
| Q1 25 | $46.0M | $93.5M | ||
| Q4 24 | $59.1M | $93.5M | ||
| Q3 24 | $80.5M | $89.8M | ||
| Q2 24 | $47.1M | $85.7M | ||
| Q1 24 | $43.8M | $83.3M |
净利润PBYISYBT
| Q4 25 | — | $36.6M | ||
| Q3 25 | $8.8M | $36.2M | ||
| Q2 25 | $5.9M | $34.0M | ||
| Q1 25 | $3.0M | $33.3M | ||
| Q4 24 | — | $31.7M | ||
| Q3 24 | $20.3M | $29.4M | ||
| Q2 24 | $-4.5M | $27.6M | ||
| Q1 24 | $-4.8M | $25.9M |
毛利率PBYISYBT
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISYBT
| Q4 25 | 22.7% | 45.9% | ||
| Q3 25 | 17.6% | 45.0% | ||
| Q2 25 | 12.7% | 43.9% | ||
| Q1 25 | 8.7% | 44.5% | ||
| Q4 24 | 22.6% | 41.9% | ||
| Q3 24 | 27.4% | 41.2% | ||
| Q2 24 | -4.6% | 41.2% | ||
| Q1 24 | -5.3% | 39.5% |
净利率PBYISYBT
| Q4 25 | — | 35.1% | ||
| Q3 25 | 16.2% | 35.7% | ||
| Q2 25 | 11.2% | 34.8% | ||
| Q1 25 | 6.5% | 35.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | 25.2% | 32.7% | ||
| Q2 24 | -9.6% | 32.2% | ||
| Q1 24 | -11.0% | 31.1% |
每股收益（稀释后）PBYISYBT
| Q4 25 | $0.26 | $1.24 | ||
| Q3 25 | $0.17 | $1.23 | ||
| Q2 25 | $0.12 | $1.15 | ||
| Q1 25 | $0.06 | $1.13 | ||
| Q4 24 | $0.40 | $1.07 | ||
| Q3 24 | $0.41 | $1.00 | ||
| Q2 24 | $-0.09 | $0.94 | ||
| Q1 24 | $-0.10 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $26.8M |
| 股东权益账面价值 | $130.3M | $1.1B |
| 总资产 | $216.3M | $9.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资PBYISYBT
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYISYBT
| Q4 25 | $22.7M | $26.8M | ||
| Q3 25 | $34.0M | $26.8M | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $26.8M | ||
| Q4 24 | $68.0M | $26.8M | ||
| Q3 24 | $79.3M | $26.8M | ||
| Q2 24 | $90.7M | $26.8M | ||
| Q1 24 | $102.0M | $26.8M |
股东权益PBYISYBT
| Q4 25 | $130.3M | $1.1B | ||
| Q3 25 | $115.3M | $1.0B | ||
| Q2 25 | $104.7M | $1.0B | ||
| Q1 25 | $97.1M | $975.5M | ||
| Q4 24 | $92.1M | $940.5M | ||
| Q3 24 | $71.1M | $934.1M | ||
| Q2 24 | $48.5M | $894.5M | ||
| Q1 24 | $51.0M | $874.7M |
总资产PBYISYBT
| Q4 25 | $216.3M | $9.5B | ||
| Q3 25 | $202.9M | $9.3B | ||
| Q2 25 | $194.9M | $9.2B | ||
| Q1 25 | $196.2M | $9.0B | ||
| Q4 24 | $213.3M | $8.9B | ||
| Q3 24 | $220.7M | $8.4B | ||
| Q2 24 | $205.0M | $8.3B | ||
| Q1 24 | $214.1M | $8.1B |
负债/权益比PBYISYBT
| Q4 25 | 0.17× | 0.02× | ||
| Q3 25 | 0.30× | 0.03× | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 0.03× | ||
| Q4 24 | 0.74× | 0.03× | ||
| Q3 24 | 1.12× | 0.03× | ||
| Q2 24 | 1.87× | 0.03× | ||
| Q1 24 | 2.00× | 0.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $166.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $154.0M |
| 自由现金流率自由现金流/营收 | 19.1% | 147.5% |
| 资本支出强度资本支出/营收 | 0.0% | 11.5% |
| 现金转化率经营现金流/净利润 | — | 4.54× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $260.5M |
8季度趋势，按日历期对齐
经营现金流PBYISYBT
| Q4 25 | $14.4M | $166.0M | ||
| Q3 25 | $9.7M | $38.2M | ||
| Q2 25 | $14.1M | $55.9M | ||
| Q1 25 | $3.6M | $19.8M | ||
| Q4 24 | $15.6M | $142.9M | ||
| Q3 24 | $11.0M | $55.4M | ||
| Q2 24 | $1.0M | $51.1M | ||
| Q1 24 | $11.2M | $17.4M |
自由现金流PBYISYBT
| Q4 25 | $14.4M | $154.0M | ||
| Q3 25 | $9.7M | $35.2M | ||
| Q2 25 | $14.1M | $53.5M | ||
| Q1 25 | $3.6M | $17.8M | ||
| Q4 24 | $15.6M | $133.0M | ||
| Q3 24 | $11.0M | $53.9M | ||
| Q2 24 | $1.0M | $47.9M | ||
| Q1 24 | — | $15.6M |
自由现金流率PBYISYBT
| Q4 25 | 19.1% | 147.5% | ||
| Q3 25 | 17.7% | 34.6% | ||
| Q2 25 | 26.8% | 54.7% | ||
| Q1 25 | 7.7% | 19.1% | ||
| Q4 24 | 26.4% | 142.3% | ||
| Q3 24 | 13.7% | 60.0% | ||
| Q2 24 | 2.1% | 55.9% | ||
| Q1 24 | — | 18.7% |
资本支出强度PBYISYBT
| Q4 25 | 0.0% | 11.5% | ||
| Q3 25 | 0.0% | 3.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.0% | 10.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 3.8% | ||
| Q1 24 | 0.0% | 2.2% |
现金转化率PBYISYBT
| Q4 25 | — | 4.54× | ||
| Q3 25 | 1.10× | 1.05× | ||
| Q2 25 | 2.41× | 1.64× | ||
| Q1 25 | 1.21× | 0.59× | ||
| Q4 24 | — | 4.51× | ||
| Q3 24 | 0.54× | 1.89× | ||
| Q2 24 | — | 1.85× | ||
| Q1 24 | — | 0.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
